![]() |
시장보고서
상품코드
1733259
세계의 온라인 약국(E Pharmacy) 시장 : 약제 유형별, 제품 유형별, 지역별(2026-2032년)E Pharmacy Market By Drug Type (Prescription Drugs, Over the Counter Drugs), Product Type (Skin Care, Dental, Cold, Flu, Vitamins) & Region for 2026-2032 |
스마트폰과 인터넷 연결의 보급으로 온라인 의약품 쇼핑이 더 많은 사람들에게 친숙해졌고, 고객들은 집에서 처방전이나 일반 의약품을 편리하게 구입할 수 있게 되었습니다. 둘째, 코로나19 사태로 촉발된 의료 서비스의 디지털화 진행으로 원격 의료와 온라인 진료가 널리 수용되면서 온라인 약국(E Pharmacy) 서비스 수요는 2024년 809억 6,000만 달러를 넘어 2032년에는 2,425억 4,000만 달러에 달할 것으로 예측됩니다.
개인 맞춤형 의료와 복약 관리에 대한 관심이 높아지면서 온라인 약국(E Pharmacy)은 맞춤형 복약 알림, 건강 모니터링 도구 제공 등 서비스 제공의 혁신을 촉진하고 경쟁이 치열해지는 시장에서 고객 만족도와 충성도를 높이고 있으며, 2026-2032년 연평균 복합 성장률(CAGR)은 약 14.70%를 보일 것으로 예측됩니다.
온라인 약국(E Pharmacy) 시장의 정의/개요
온라인 약국(E Pharmacy)은 인터넷 기반 플랫폼을 통해 의약품 및 건강 관련 상품을 온라인으로 판매 및 유통하는 것을 말합니다. 이 전략을 통해 고객은 집에서 처방약, 일반의약품, 건강보조식품, 퍼스널케어 제품을 쉽게 구할 수 있습니다. 온라인 약국(E Pharmacy)의 용도에는 온라인 처방전 보충, 원격 의료 상담, 건강 모니터링 서비스, 고객에게 직접 의약품 배달 등이 포함됩니다. 온라인 약국(E Pharmacy)의 미래는 낙관적이며, 디지털 건강 기술의 발전, 인터넷 접속 증가, 효율적인 의료 솔루션에 대한 수요 증가는 온라인 약국(E Pharmacy)의 발전의 원동력이 될 것으로 예측됩니다. 의약품의 온라인 판매를 허용하는 규칙이 조정되고 e-헬스의 이점에 대한 소비자의 인식이 높아짐에 따라 온라인 약국(E Pharmacy) 사업은 빠르게 확장되어 보다 개인화된 서비스와 향상된 고객 경험을 제공하게 될 것입니다.
맞춤형 의료에 대한 관심이 높아지면서 온라인 약국(E Pharmacy) 산업은 크게 성장할 것으로 예측됩니다. 2023년 9월, 원격의료 플랫폼 Teladoc Health는 환자 개인별 맞춤형 약물 치료 및 건강 추천을 제공하기 위해 데이터 분석과 인공지능을 사용하여 환자의 참여와 웰빙을 향상시키는 새로운 맞춤형 의료 프로젝트를 도입한다고 발표했습니다. 강화하는 것을 목표로 하는 새로운 맞춤형 의료 프로젝트를 도입한다고 발표했습니다. 이러한 움직임은 개인화된 의료를 지향하는 광범위한 업계 추세를 반영하며, 온라인 약국(E Pharmacy)이 맞춤형 건강 솔루션에 대한 수요에 대응할 수 있는 유리한 위치에 있음을 시사합니다.
예를 들어, 미국 식품의약국(FDA)은 2023년 7월 개인 맞춤형 의료를 지원하는 디지털 건강 기술의 사용을 장려하는 가이드라인을 발표하여 이러한 접근 방식을 기존 의료 시스템에 통합할 필요성을 강조했습니다. 약국 시장은 개인 맞춤형 의료 서비스에 대한 수요 증가로 인해 2024년부터 2032년까지 연평균 복합 성장률(CAGR) 14.70%를 보일 것으로 예측됩니다. 이러한 기술 혁신과 적절한 법적 프레임워크의 결합으로 소비자가 개인화된 의료 솔루션을 원하게 되면서 온라인 약국(E Pharmacy) 분야는 성장할 것입니다.
의약품 판매에 대한 규제 강화는 온라인 약국에게 다양한 법률을 준수하는 것이 큰 걸림돌로 작용하여 온라인 약국(E Pharmacy) 비즈니스의 성장을 저해할 수 있습니다. 많은 국가의 규제 기관은 의약품의 안전성을 보장하기 위해 허가 인증, 의약품 품질 모니터링, 환자 프라이버시 보호 등 엄격한 기준을 마련하고 있습니다. 온라인 약국(E Pharmacy)은 이러한 복잡한 규칙을 관리해야 하며, 이는 운영 비용과 관리상의 번거로움을 증가시킬 수 있습니다. 특히 소규모 기업은 이러한 기준을 충족하는 데 어려움을 겪을 수 있으며, 그 결과 시장에서의 경쟁과 혁신이 저하될 수 있습니다. 또한, 컴플라이언스 위반의 위험은 온라인 약국(E Pharmacy) 시장에 새로 진입하려는 기업들의 의욕을 떨어뜨려 전반적인 성장 전망을 제한할 수 있습니다.
엄격한 규칙은 장애물이 될 수 있지만, 고객의 신뢰와 안전성을 높이는 데 도움이 되어 장기적인 시장 성장에 긍정적인 영향을 미칠 수 있습니다. 규제 프레임워크가 더 확립되면 소비자들은 온라인으로 의약품을 주문하는 데 자신감을 갖게 되고, 평판이 좋은 온라인 약국(E Pharmacy) 서비스에 대한 수요가 늘어날 수 있습니다. 이러한 환경에서 규정을 성공적으로 준수하는 온라인 약국(E Pharmacy)은 평판과 신뢰도 향상을 통해 차별화를 꾀하고 시장 점유율을 확대할 수 있을 것입니다. 마지막으로, 규제 강화가 온라인 약국(E Pharmacy) 비즈니스에 미치는 영향은 기업이 사용자 참여와 서비스 품질을 유지하면서 컴플라이언스 요구사항에 얼마나 잘 적응할 수 있는지에 따라 결정될 것입니다.
The growing use of smartphones and internet connectivity has made online medication shopping more accessible to a wider audience, allowing customers to conveniently obtain prescriptions and over-the-counter drugs from the comfort of their own homes. Second, the ongoing digitization of healthcare services, spurred by the COVID-19 pandemic, has led to a wider acceptance of telehealth and online consultations, increasing demand for e-pharmacy services is surpassing USD 80.96 Billion in 2024 and reaching USD 242.54 Billion by 2032.
The growing emphasis on personalized healthcare and medication management has prompted e-pharmacies to innovate their service offerings, such as providing customized medication reminders and health monitoring tools, thereby increasing customer satisfaction and loyalty in an increasingly competitive market is expected to grow at a CAGR of about 14.70% from 2026 to 2032.
E Pharmacy Market: Definition/ Overview
E-pharmacy, or electronic pharmacy, is the online selling and distribution of pharmaceuticals and health-related items via internet-based platforms. This strategy enables customers to easily obtain prescription and over-the-counter pharmaceuticals, health supplements, and personal care products from the comfort of their own homes. E-pharmacy applications include online prescription refills, telemedicine consultations, health monitoring services, and direct pharmaceutical delivery to customers. The future of e-pharmacy seems optimistic, with development expected to be driven by advances in digital health technologies, increased internet access, and rising demand for efficient healthcare solutions. As rules adapt to allow online pharmaceutical sales and consumer awareness of e-health benefits grows, the e-pharmacy business is likely to increase rapidly, providing more personalized services and improved customer experiences.
The growing emphasis on personalized healthcare is expected to fuel significant growth in the e-pharmacy industry, as customers seek tailored solutions to meet their individual health demands. With technological improvements, e-pharmacies are using data analytics and artificial intelligence to give personalized drug regimens and health recommendations, hence increasing patient engagement and happiness. In September 2023, Teladoc Health, a telehealth platform, announced the introduction of a new personalized medicine project aiming at enhancing treatment plans based on unique patient profiles. This move mirrors a broader industry trend toward personalized healthcare, implying that e-pharmacies are well-positioned to address the demand for customized health solutions.
For instance, in July 2023, the US Food and Drug Administration (FDA) issued guidelines encouraging the use of digital health technologies to support personalized medicine, highlighting the necessity of incorporating these approaches into existing healthcare systems. According to Verified Market Research, the e-pharmacy market will develop at a CAGR of 14.70% between 2024 and 2032, driven by increased demand for individualized healthcare services. This convergence of technical innovation and appropriate legal frameworks sets the e-pharmacy sector for growth as consumers desire personalized healthcare solutions.
Growing rules governing the selling of medications may stymie the expansion of the e-pharmacy business, as complying with various laws creates substantial obstacles for online pharmacies. Many countries' regulatory agencies have created severe criteria to assure medicine safety, such as licensing verification, drug quality monitoring, and patient privacy protection. E-pharmacies must manage these complex rules, which can raise operating costs and administrative hassles. Smaller companies, in particular, may struggle to fulfill these criteria, resulting in less competition and innovation in the market. Furthermore, the risk of non-compliance can dissuade new participants from entering the e-pharmacy market, restricting overall growth prospects.
While strict rules may provide obstacles, they also help to increase customer trust and safety, which could have a positive impact on long-term market growth. As regulatory frameworks become more established, consumers may gain confidence in ordering pharmaceuticals online, increasing demand for reputable e-pharmacy services. In this environment, e-pharmacies that successfully comply with rules may distinguish themselves through increased reputation and reliability, potentially acquiring a larger share of the market. Finally, the impact of increased restrictions on the e-pharmacy business will be determined by how well enterprises adapt to compliance needs while preserving user engagement and service quality.
The increasing demand for prescription pharmaceuticals is expected to considerably boost the growth of the e-pharmacy industry, owing to factors such as increased chronic disease prevalence and the convenience of online ordering. As more patients require continuing medicine for ailments such as diabetes, hypertension, and mental health difficulties, e-pharmacies are well-positioned to address this growing demand by giving convenient access to important drugs. For instance, in September 2023, CVS Health declared a strategic focus on increasing its digital health services, highlighting the necessity of online prescriptions to improve patient access and drug management. This move highlights the synchronization of traditional pharmacy operations with consumers' changing requirements, demonstrating how established enterprises are shifting to capitalize on the e-pharmacy boom.
Furthermore, government initiatives promoting telehealth and digital healthcare solutions boost the e-pharmacy market's growth prospects. For instance, in April 2023, the United States Department of Health and Human Services (HHS) issued new guidelines to make telehealth services, such as online prescription refills, more accessible, particularly for mental health and substance use issues. These regulations aim to increase healthcare access for marginalized groups, which will have a direct influence on the e-pharmacy business by encouraging more patients to use online services for their prescriptions.
In contrast, the over-the-counter (OTC) pharmaceuticals segment is the fastest-growing category, driven by rising consumer awareness of health and wellness, as well as the convenience of ordering OTC meds online. The growing tendency of self-medication, particularly among younger consumers who prefer the convenience of online purchase, is driving this segment's expansion.
The rising number of cold and flu cases is expected to generate significant growth in the e-pharmacy market, as more consumers seek easy and rapid access to over-the-counter pharmaceuticals and health items online. With a growing occurrence of respiratory illnesses, particularly during seasonal peaks, e-pharmacies are becoming a popular choice for those who want to treat their symptoms without having to visit a real pharmacy. In October 2023, Walgreens reported an increase in online sales of cold and flu treatments, reflecting consumer preferences toward seeking fast relief via digital platforms. The convenience of online buying, especially during illness when going out may be less tempting, allows e-pharmacies to grab a higher market share in this area.
For instance, in September 2023, the Centers for Disease Control and Prevention (CDC) initiated a campaign advocating vaccination and early treatment of flu symptoms, resulting in increased consumer demand for cold and flu treatments. The emphasis on accessibility and quick reaction to disease is well aligned with the ability of e-pharmacies to deliver health supplies directly to consumers' homes.
However, the skin care area is emerging as the fastest-growing category, owing to increased consumer interest in personal wellbeing, cosmetic products, and preventative healthcare. With the rise of social media and online beauty trends, more people are turning to e-pharmacies for skincare solutions, which include both medicinal and cosmetic items. This shift toward skin health and wellbeing reflects a substantial change in consumer behavior, setting the skin care category for strong growth in the e-pharmacy market.
Country/Region-wise
The high internet access in North America is a major driver of the e-pharmacy sector. As of 2023, the Internet and Mobile Association of North America claimed that internet penetration in the region had reached 94.6%, with 392 million people routinely accessing online services. This high level of connection has made the environment ideal for the growth of e-pharmacy services. In February 2024, the Federal Communications Commission (FCC) revealed that 99% of Americans now have broadband internet connection, up from 93.5% in 2020. This enhanced accessibility has enabled more consumers to use online pharmacy services, particularly in rural areas where physical pharmacies are less accessible. The ease of obtaining prescriptions online, together with the opportunity to readily compare prices and access health information, has led to a surge in e-pharmacy adoption.
In March 2024, Amazon Pharmacy reported a 45% year-over-year rise in prescription orders, citing greater internet access and shifting consumer preferences. Similarly, CVS Health said in January 2024 that their digital pharmacy revenues had increased by 38% over the previous year, accounting for 25% of all prescription fills. On the regulatory front, the U.S. Food and Drug Administration (FDA) published new rules in September 2023 to make it easier for e-pharmacies to obtain licenses in several states, with the goal of facilitating the growth of online pharmacy services. A poll done by the National Association of Boards of Pharmacy in July 2023 indicated that 62% of North American customers have used an online pharmacy service at least once in the previous year.
The Asia-Pacific region's increased desire for convenient drug access is expected to considerably accelerate the e-pharmacy industry, led by a growing population that is increasingly reliant on digital healthcare solutions. As more consumers in this region adopt online shopping and mobile applications, the e-pharmacy sector stands to benefit from the desire for convenient access to both prescription and over-the-counter drugs. For instance, in August 2023, India-based e-pharmacy PharmEasy reported a 60% growth in online medication orders, owing to a growing preference for home delivery. This trend demonstrates the region's shift toward digital healthcare solutions, as well as how convenience influences customer behavior.
Furthermore, government initiatives in the Asia-Pacific region are boosting the e-pharmacy market's growth prospects. In June 2023, the Chinese government issued new policies to promote the digitalization of healthcare services, including online pharmaceutical sales, with the goal of improving access for rural communities.
Competitive Landscaped
The competitive landscape of the e-pharmacy market is characterized by a dynamic interplay of established pharmacy chains, technology-driven startups, and online healthcare service providers. This market features a mix of local and global players, each vying for a share through innovative services, competitive pricing, and extensive product offerings. Companies are increasingly focusing on enhancing customer experience through user-friendly mobile apps and websites, along with personalized services such as telehealth consultations and medication reminders. Additionally, strategic partnerships and collaborations with healthcare providers and technology firms are becoming common as e-pharmacies seek to expand their reach and improve service delivery. Regulatory compliance and maintaining quality standards are also critical factors that influence competitive positioning in this rapidly evolving sector.
Some of the prominent players operating in the E pharmacy market include:
CVS Health Corporation
DocMorris
Express Scripts Holding Company
Giant Eagle,
Optum Rx,
Rowlands Pharmacy
The Kroger Co.
Walgreen Co.
Walmart Stores,
In August 2023, Walgreens announced the development of its digital health services, with an emphasis on improving its e-pharmacy platform. In response to the increased demand for online healthcare solutions, the firm plans to improve the user experience with an upgraded mobile app that makes prescription refills and medication monitoring easier.
In September 2023, India-based e-pharmacy PharmEasy announced a strategic agreement with local healthcare providers to deliver individualized drug management services. This alliance seeks to improve patient participation and ensure timely delivery of critical medications, reflecting the growing emphasis on individualized healthcare solutions.